We report a case of a 73-year-old male with heterochronous triple urogenital cancer.
The patient was referred to our hospital because serum PSA was elevated (7.0 ng/ml) in 1998. Prostatic needle biopsy revealed prostatic cancer in the right lobe, and total prostatectomy was performed. The histopathological diagnosis was moderately differentiated adenocarcinoma (TlcNOMO). Non-muscle invasive bladder cancer (NMIBC) was detected during an examination for microhematuria in 2002. Transurethral resection of the bladder tumor (TURBT) procedure was performed, and the histopathological diagnosis was grade 2 urothelial carcinoma (pTa). A right renal mass was detected incidentally on follow-up CT for bladder cancer in 2008. Renal enucleation was performed in 2009. The histopathological diagnosis was grade 2 clear cell renal cell carcinoma (pTlaNXMO). NMIBC was detected on follow-up urethrocystoscopy in 2011. The TURBT procedure was performed, and the histopathological diagnosis was grade 2 urothelial carcinoma (pTa). On follow-up for urogenital cancer patients, it is important to investigate recurrence of the primary cancer and also heterochronous canceration of other urogenital organs.
Written by:
Okumura A, Tsuritani S, Takagawa K, Fuse H. Are you the author?
Department of Urology, Kurobe City Hospital; Department of Clinical Laboratory, Kurobe City Hospital; Department of Urology, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama.
Reference: Nihon Hinyokika Gakkai Zasshi. 2013 Nov;104(6):702-5.
PubMed Abstract
PMID: 24564077
Article in Japanese.
UroToday.com Renal Cancer Section
